S. 92 (119th)Bill Overview

Defending American Sovereignty in Global Pandemics Act

International Affairs|International Affairs
Cosponsors
Support
Republican
Introduced
Jan 14, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Foreign Relations. (text: CR S140)

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill bars the United States from becoming a party to any World Health Organization (WHO) convention or agreement to strengthen pandemic prevention, preparedness, or response unless that instrument is submitted and ratified as a treaty under Article II, section 2, clause 2 of the U.S. Constitution. It also prohibits the U.S. government from obligating or spending funds for the WHO beginning on the effective date of any such WHO pandemic agreement and continuing until the Senate approves a resolution of ratification for that agreement.

Why people may split

Progressives emphasize public-health and cooperation harms

Watch point

Relative to its intended legislative type, this bill delivers a clear, narrowly focused substantive policy change (a Senate-ratification requirement and a funding suspension) but provides limited operational, fiscal, and oversight detail.

The bill bars the United States from becoming a party to any World Health Organization (WHO) convention or agreement to strengthen pandemic prevention, preparedness, or response unless that instrument is submitted and ratified as a treaty under Article II, section 2, clause 2 of the U.S. Constitution.

It also prohibits the U.S. government from obligating or spending funds for the WHO beginning on the effective date of any such WHO pandemic agreement and continuing until the Senate approves a resolution of ratification for that agreement.

Passage30/100

Narrow text but politically charged; blunt funding suspension and lack of compromise reduce cross‑chamber appeal.

CredibilityPartially aligned

Relative to its intended legislative type, this bill delivers a clear, narrowly focused substantive policy change (a Senate-ratification requirement and a funding suspension) but provides limited operational, fiscal, and oversight detail.

Contention72/100

Progressives emphasize public-health and cooperation harms

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedCities

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitReinforces the Constitution's treaty ratification role of the Senate for international pandemic agreements.
  • Potential benefitRequires greater legislative oversight and public debate before ceding authority to international health instruments.
  • Potential benefitCreates leverage by conditioning U.S. WHO funding on full Senate approval of agreement terms.
Likely burdened
  • CitiesTemporary U.S. funding suspension could reduce WHO capacity for surveillance, technical assistance, and outbreak respon…
  • Potential burdenDelaying U.S. participation may weaken international coordination during emerging pandemics.
  • Potential burdenLoss of U.S. financial contributions could diminish American influence in shaping WHO policies and standards.
03 · Why people split

Why the argument around this bill splits.

Progressives emphasize public-health and cooperation harms
Progressive15%

Likely views the bill negatively because it conditions U.S. pandemic cooperation on Senate treaty ratification and suspends WHO funding.

Concerned this could hamper international coordination and weaken global and domestic pandemic readiness.

Likely resistant
Centrist50%

Mixed reaction: supports constitutional review of binding international commitments but worries about the funding suspension’s operational effects.

Would seek a balance preserving oversight while avoiding interruptions to preparedness.

Split reaction
Conservative90%

Generally supportive: views bill as protecting U.S. sovereignty by requiring Senate ratification before any binding WHO pandemic agreement.

Sees funding suspension as leverage to prevent ceding authority to international bodies.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood30/100

Narrow text but politically charged; blunt funding suspension and lack of compromise reduce cross‑chamber appeal.

Scope and complexity
52%
Scopemoderate
24%
Complexitylow
Why this could stall
  • No cost estimate or scale of WHO funding impact provided
  • Whether an applicable WHO pandemic agreement already exists or timing
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressives emphasize public-health and cooperation harms

Narrow text but politically charged; blunt funding suspension and lack of compromise reduce cross‑chamber appeal.

Unlocked analysis

Relative to its intended legislative type, this bill delivers a clear, narrowly focused substantive policy change (a Senate-ratification requirement and a funding suspension) but provides limited operational, fiscal, an…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis